Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label RA. Show all posts
Showing posts with label RA. Show all posts
Monday, November 24, 2014

New drug combination shows promise as effective, safe treatment for rheumatoid arthritis

›
A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medi...
Monday, July 23, 2012

RA Study Misses Primary Endpoint (CH-4051)...

›
In continuation of my update on CH-4051 Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a preliminary analysis of...
Friday, June 1, 2012

FDA AAC recommends approval of Pfizer’s tofacitinib for RA

›
In continuation of my update on  Tofacitinib ... FDA AAC recommends approval of Pfizer’s tofacitinib for RA : Pfizer Inc. the Arthriti...
Wednesday, May 23, 2012

Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill

›
In continuation of my update on Tofacitinib Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill : Pfizer is waiting...
Sunday, June 19, 2011

FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA

›
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA
Tuesday, May 31, 2011

UCB,s new data for Cimzia® (certolizumab pegol) showed a rapid clinical response across a broad population of RA patients

›
UCB, announced data which showed that the addition of Cimzia ® ( certolizumab pegol ) to current therapy was associated with a rapid and ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.